Regulatory compliance, Data Integrity, Implementation of innovative technologies, Time bound services, Customer focus and Cost-effectiveness are the cornerstones upon which the company thrives
Dr Venkatesh P, Managing Director
Medical advancements, the rise of chronic diseases, increasing investments in R&D portfolio, and progress in clinical trial technology are all contributing to the growth of contract research organization market. The requirement for dedicated facilities, equipped with skilled professionals and high end equipments are imperative to develop effective formulations, to address existing complex health challenges by pharmaceutical companies which presents ample opportunity for the CRO industry to continue their growth curve at a rapid pace.
Bringing a professional team with over 15 years of industry experience in this segment, Noah Therapeutics, a unique hospital based growing CRO at Hyderabad, addresses the evolving challenges of the healthcare sector. Noah Therapeutics brings unmatched expertise across a diverse range of specializations, supporting drug development process of pharmaceutical & biotech companies with its world-class capabilities and facilities. A multi-vertical organization, Noah Therapeutics is committed to providing high-quality, timely services while adhering to regulatory guidelines, ensuring customer satisfaction, and fulfilling market needs effectively.
Drug Development Support:
Holding a strategic position in the CRO market, Noah Therapeutics specializes in bioavailability (BA) and bioequivalence (BE) studies and clinical trials encompassing phase II, III, & IV, patient PK studies, vaccines, nutraceuticals, and medical devices. Beyond these, the firm also offers services such as medical and scientific writing, protocol development, bioanalytical research, project management, quality assurance, pharmacokinetics and statistics, as well as assistance in ANDA submissions.
Leveraging this extensive experience, the company effectively provides services that meet changing market needs, focusing on systems and regulatory compliance while incorporating cutting-edge technologies that accelerate the drug development process, ensuring that patients gain access to life-saving medications more quickly. Cost-effectiveness and efficiency in drug development are the cornerstones upon which the company thrives.
Regulatory compliance, Data Integrity, Implementation of innovative technologies, Time bound services, Customer focus and Cost-effectiveness are the cornerstones upon which the company thrives
Dr Venkatesh P, Managing Director
One of the key features that set Noah Therapeutics apart is the company’s focus on compliance with international regulations and maintenance of the highest standards in clinical trials. To achieve this, the firm has adopted and implemented a thorough quality management system. Additionally, it ensures stringent adherence to ICH-GCP guidelines and alignment with global regulatory requirements.
The firm also focuses on training its team about the latest regulatory updates, ethical practices, and data integrity. The integration of advanced technologies also plays a pivotal role in equipping the firm to provide transparent and accurate solutions. Moreover, the firm maintains patient safety as a top priority, informing every participant about the research in which they are being involved, proactively addressing concerns, and encouraging them to make the decision to participate without pressure and opt out at any time.
“As a unique CRO, we place patient safety at the forefront. Ethics committees rigorously review protocols to prioritize patient safety, and our comprehensive vendor and site management ensures alignment with our high-quality benchmarks”, shares Dr Venkatesh P, Managing Director, Noah Therapeutics.
As a full-service CRO, Noah Therapeutics offers end-to-end services from its state-of-the-art infrastructural facility with clinical facilities spread across 22,000 sq. ft. and comprising 84 beds, along with two fully equipped ICU units, an in-house X-ray, a dedicated pharmacy, and deep freezers. Noah Therapeutics’ bioanalytical lab is equipped with two GLP and 21 CFR Part 11 compliant LC-MS/MS systems. Spread over 4000 sq. ft., this lab is constructed in multiple buildings and comprises a sample separation room, archival room, and sample preparation room. These facilities contain all essential equipment, including centrifuges, SPE manifolds, refrigerators, vortex mixers, fume hoods, pH meters, ultrasonic baths, nitrogen evaporators, Mettler Toledo micro/analytical balances, separate pharmaceutical refrigerators, and deep freezers with restricted access.
Future Aspirations
Established in 2022, Noah Therapeutics received approval for its operations from the Central Drugs Standard Control Organization (CDSCO) in 2023 and has ever since continuously provided comprehensive drug development and research advancement services, prioritizing customer satisfaction through transparent communication, personalized service, and consistent quality delivery.
Continuing on this path, and building upon its strategic position as a dynamic CRO, Noah Therapeutics has designed a robust roadmap for its future. Envisioning a future of clinical research through the unique lens of its integrated healthcare environment within its strategic location of a multispecialty hospital premises, the company has ambitious plans for enhancing its capabilities further in the coming years.
“Our distinctive setup in a multispecialty hospital premises, combined with our state-of-the-art infrastructure, including GLP-compliant LC-MS/MS systems and advanced clinical facilities, has positioned us ideally to embrace emerging trends in clinical research such as real-world evidence studies, precision medicine, and adaptive trial designs to advance the future of drug development,”adds Dr Venkatesh.
As the company continues to grow, it remains committed to drive innovation demonstrated via its expansive service portfolio. It is optimistic about the possibilities that lie ahead and the opportunities that its highly skilled and experienced team stands ready to seize. For future, the company plans to invest a lot of its resources and time in leveraging its existing capabilities for the purpose of enhancing drug development as well as healthcare solutions. While accomplishing all this, the company aims to maintain the highest standards of quality and ensure regulatory compliance, aligned with the requirements and expectations of its partners, becoming a preferred partner for CRO solutions for the pharmaceuticals sector.
, CDSCO.jpg)
